APAC AI in Bioinformatics Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143097
- Pages: 225
-
Format:
Short Description
Asia-Pacific AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products, and Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Industry Trends, and Forecast to 2029
Market Definition
Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein, and is particularly useful in comparing genes, and other sequences in proteins and other sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.
Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.
Market Segmentation
The AI in bioinformatics market is categorized into five notable segments such as offering, type, products and services, application, and other sectors.
On the basis of offering, the Asia-Pacific AI in bioinformatics market is segmented into software, services, and others
On the basis of type, the Asia-Pacific AI in bioinformatics market is segmented into machine learning, deep learning, and others
On the basis of products and services, the Asia-Pacific AI in bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services
On the basis of application, the Asia-Pacific AI in bioinformatics market is segmented into genomics, microarrays, system biology, text mining, chemoinformatics & drug design, proteomics, transcriptomics, DNA sequencing, metabolomics, and others
On the basis of sector, the Asia-Pacific AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other sectors
Market Players
Some of the major players operating in the Asia-Pacific AI in bioinformatics market are:
SOPHiA GENETICS
Biomax Informatics Inc.
QIAGEN
NeoGenomics Laboratories
Eurofins Scientific
Illumina, Inc.
Thermofisher Scientific, Inc.
Strand Life Sciences
Dassault Systmes
SomaLogic Operating Co., Inc.
Elucidata
TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF ASIA PACIFIC AI IN BIOINFORMATICS MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 OFFERING LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 MARKET SECTOR COVERAGE GRID 41
2.11 VENDOR SHARE ANALYSIS 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTERS FIVE FORCES 49
5 MARKET OVERVIEW 50
5.1 DRIVERS 52
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 52
5.1.2 GROWING DEMAND FOR BIOINFORMATICS 53
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 53
5.2 RESTRAINTS 54
5.2.1 HIGH COST OF INSTRUMENTATION 54
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 54
5.3 OPPORTUNITIES 55
5.3.1 RISE IN HEALTHCARE EXPENDITURE 55
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 55
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 56
5.4 CHALLENGES 56
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 56
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 57
6 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY OFFERING 58
6.1 OVERVIEW 59
6.2 SERVICES 62
6.3 SOFTWARE 62
6.4 OTHERS 63
7 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY TYPE 65
7.1 OVERVIEW 66
7.2 MACHINE LEARNING 69
7.3 DEEP LEARNING 69
7.4 OTHERS 70
8 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 72
8.1 OVERVIEW 73
8.2 BIOINFORMATICS SERVICES 76
8.2.1 DATA ANALYSIS 77
8.2.2 SEQUENCING SERVICES 77
8.2.3 DATABASE MANAGEMENT 77
8.2.4 OTHERS 77
8.3 BIOINFORMATICS PLATFORMS 77
8.3.1 SEQUENCE ANALYSIS PLATFORMS 78
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 78
8.3.3 STRUCTURAL ANALYSIS PLATFORMS 79
8.3.4 SEQUENCE MANIPULATION PLATFORMS 79
8.3.5 OTHERS 79
8.4 KNOWLEDGE MANAGEMENT TOOLS 79
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 80
9 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY APPLICATION 81
9.1 OVERVIEW 82
9.2 GENOMICS 85
9.3 CHEMOINFORMATICS & DRUG DESIGN 85
9.4 PROTEOMICS 86
9.5 DNA SEQUENCING 87
9.6 SYSTEM BIOLOGY 88
9.7 TRANSCRIPTOMICS 89
9.8 TEXT MINING 90
9.9 MICROARRAYS 91
9.10 METABOLOMICS 92
9.11 OTHERS 93
10 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY SECTOR 94
10.1 OVERVIEW 95
10.2 MEDICAL BIOTECHNOLOGY 98
10.3 ANIMAL BIOTECHNOLOGY 98
10.4 PLANT BIOTECHNOLOGY 99
10.5 ENVIRONMENTAL BIOTECHNOLOGY 100
10.6 FORENSIC BIOTECHNOLOGY 101
10.7 OTHERS 102
11 ASIA PACIFIC AI IN BIOINFORMATICS MARKET, BY REGION 103
11.1 ASIA-PACIFIC 104
11.1.1 CHINA 111
11.1.2 JAPAN 114
11.1.3 SOUTH KOREA 117
11.1.4 INDIA 120
11.1.5 AUSTRALIA 123
11.1.6 SINGAPORE 126
11.1.7 THAILAND 129
11.1.8 MALAYSIA 132
11.1.9 INDONESIA 135
11.1.10 PHILIPPINES 138
11.1.11 REST OF ASIA-PACIFIC 141
12 ASIA PACIFIC AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 142
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 142
13 SWOT ANALYSIS 143
14 COMPANY PROFILES 144
14.1 ILLUMINA, INC. 144
14.1.1 COMPANY SNAPSHOT 144
14.1.2 REVENUE ANALYSIS 144
14.1.3 COMPANY SHARE ANALYSIS 145
14.1.4 PRODUCT PORTFOLIO 145
14.1.5 RECENT DEVELOPMENTS 145
14.2 DASSAULT SYSTEMES 146
14.2.1 COMPANY SNAPSHOT 146
14.2.2 REVENUE ANALYSIS 146
14.2.3 COMPANY SHARE ANALYSIS 147
14.2.4 PRODUCT PORTFOLIO 147
14.2.5 RECENT DEVELOPMENT 147
14.3 EUROFINS SCIENTIFIC 148
14.3.1 COMPANY SNAPSHOT 148
14.3.2 REVENUE ANALYSIS 148
14.3.3 COMPANY SHARE ANALYSIS 149
14.3.4 PRODUCT PORTFOLIO 149
14.3.5 RECENT DEVELOPMENTS 149
14.4 THERMO FISHER SCIENTIFIC INC. 150
14.4.1 COMPANY SNAPSHOT 150
14.4.2 REVENUE ANALYSIS 150
14.4.3 COMPANY SHARE ANALYSIS 151
14.4.4 PRODUCT PORTFOLIO 151
14.4.5 RECENT DEVELOPMENTS 151
14.5 QIAGEN 152
14.5.1 COMPANY SNAPSHOT 152
14.5.2 COMPANY SHARE ANALYSIS 152
14.5.3 PRODUCT PORTFOLIO 152
14.5.4 RECENT DEVELOPMENTS 152
14.6 SOPHIA GENETICS 153
14.6.1 COMPANY SNAPSHOT 153
14.6.2 PRODUCT PORTFOLIO 153
14.6.3 RECENT DEVELOPMENT 153
14.7 ARDIGEN 154
14.7.1 COMPANY SNAPSHOT 154
14.7.2 PRODUCT PORTFOLIO 154
14.7.3 RECENT DEVELOPMENTS 154
14.8 BIOMAX INFORMATICS AG 155
14.8.1 COMPANY SNAPSHOT 155
14.8.2 PRODUCT PORTFOLIO 155
14.8.3 RECENT DEVELOPMENT 155
14.9 CELBRIDGESCIENCE. 156
14.9.1 COMPANY SNAPSHOT 156
14.9.2 PRODUCT PORTFOLIO 156
14.9.3 RECENT DEVELOPMENTS 156
14.10 DNASTAR 157
14.10.1 COMPANY SNAPSHOT 157
14.10.2 PRODUCT PORTFOLIO 157
14.10.3 RECENT DEVELOPMENTS 157
14.11 ELUCIDATA 158
14.11.1 COMPANY SNAPSHOT 158
14.11.2 PRODUCT PORTFOLIO 158
14.11.3 RECENT DEVELOPMENTS 158
14.12 FIOS GENOMICS 159
14.12.1 COMPANY SNAPSHOT 159
14.12.2 PRODUCT PORTFOLIO 159
14.12.3 RECENT DEVELOPMENTS 159
14.13 INDX. AI. 160
14.13.1 COMPANY SNAPSHOT 160
14.13.2 PRODUCT PORTFOLIO 160
14.13.3 RECENT DEVELOPMENTS 160
14.14 INSILICO MEDICINE 161
14.14.1 COMPANY SNAPSHOT 161
14.14.2 PRODUCT PORTFOLIO 161
14.14.3 RECENT DEVELOPMENTS 161
14.15 JADBIO & GNOSIS DATA ANALYSIS 163
14.15.1 COMPANY SNAPSHOT 163
14.15.2 PRODUCT PORTFOLIO 163
14.15.3 RECENT DEVELOPMENTS 163
14.16 NEOGENOMICS LABORATORIES 165
14.16.1 COMPANY SNAPSHOT 165
14.16.2 REVENUE ANALYSIS 165
14.16.3 PRODUCT PORTFOLIO 166
14.16.4 RECENT DEVELOPMENTS 166
14.17 PAIGE AI, INC. 167
14.17.1 COMPANY SNAPSHOT 167
14.17.2 PRODUCT PORTFOLIO 167
14.17.3 RECENT DEVELOPMENTS 167
14.18 SOMALOGIC OPERATING CO., INC. 168
14.18.1 COMPANY SNAPSHOT 168
14.18.2 PRODUCT PORTFOLIO 168
14.18.3 RECENT DEVELOPMENTS 168
14.19 SOURCE BIOSCIENCE. 169
14.19.1 COMPANY SNAPSHOT 169
14.19.2 PRODUCT PORTFOLIO 169
14.19.3 RECENT DEVELOPMENTS 169
14.20 STRAND LIFE SCIENCES 170
14.20.1 COMPANY SNAPSHOT 170
14.20.2 PRODUCT PORTFOLIO 170
14.20.3 RECENT DEVELOPMENTS 170
15 QUESTIONNAIRE 171
16 RELATED REPORTS 174
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
